1
|
60 (±5)
|
M
|
Acute leukaemia
|
No prior chemotherapy
|
Asphyxia
|
229
|
2
|
70 (±5)
|
F
|
Acute leukaemia
|
Curative
|
Cancer bleeding
|
2
|
3
|
75 (±5)
|
M
|
Stomach cancer
|
More than 3rd line
|
Procedure-related complication
|
135
|
4
|
65 (±5)
|
M
|
Colon cancer
|
More than 3rd line
|
Infection related chemotherapy
|
1568a
|
5
|
70 (±5)
|
F
|
Stomach cancer
|
1st palliative
|
Aspiration
|
66
|
6
|
70 (±5)
|
M
|
Lung cancer
|
More than 3rd line
|
Cancer related hypercalcaemia
|
12
|
7
|
70 (±5)
|
F
|
CML
|
Curative
|
Dye hypersensitivity
|
2225a
|
8
|
85 (±5)
|
F
|
Lung cancer
|
1st palliative
|
Infection related chemotherapy
|
2
|
9
|
80 (±5)
|
M
|
Multiple myeloma
|
1st palliative
|
Ventricular tachycardia
|
380
|
10
|
60 (±5)
|
M
|
Pancreatic cancer
|
1st palliative
|
Infection-related chemotherapy
|
12
|
11
|
70 (±5)
|
F
|
Acute leukaemia
|
Curative
|
Infection-related chemotherapy
|
9
|
12
|
60 (±5)
|
F
|
Colon
|
More than 3rd line
|
Ventricular fibrillation
|
2
|